Newsletters

Q2 2020 Excelsior Newsletter

The Rebate Bubble by Jonalan Smith, PharmD, FASCP, Senior Vice President Everyone knows the recent ‘bubbles’ that have impacted the economy in major way: The

Read More »

ICER Update 02.27.20

Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update.Here is this week’s ICER recap: ICER released a Draft Evidence Report for

Read More »

ICER Update 03.23.20

NOTE: Since today’s update was written, ICER has announced either the indefinite postponement (Sickle Cell Disease, Cystic Fibrosis) or 2 to 3 month delay (NASH,

Read More »

ICER Update 01.29.20

Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER released a draft evidence report

Read More »

Q4 2019 Excelsior Newsletter

HIV PrEP Therapies by Darian Hurst, Vice President In June 2019, the United States Preventive Services Task Force (USPSTF) published a final recommendation that clinicians

Read More »

ICER Update 10.21.19

Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER released an updated Draft Evidence

Read More »

ICER Update 10.07.19

Hello, everyone, and welcome to a very full edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER posted a Draft Scoping

Read More »

ICER Update 09.30.19

Hello, everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: 1. ICER released a Draft Evidence Report

Read More »

Q3 2019 Excelsior Newsletter

Specialty Drug Manufacturer Assistance Programs And Your Plan by Sarah Martin, ASA, MAAA, FCA, CEBS, Vice President Manufacturer assistance, also known as patient assistance programs, copay

Read More »
Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on whatsapp